Presents the recommendations of a work group in preventing cardiovascular diseases in the United States. Availability of literature tabulations on the relationship between cardiovascular diseases and occupation; Need of resources in studying occupational factors; Improvement in the educational activities among...
Many cardiovascular technologies are at or near the world’s leading level, and significant progress has been achieved in China solving the problem of “treatment difficulty” of cardiovascular diseases (CVD). However, due to the prevalence of unhealthy lifestyles among Chinese residents, a huge ...
Over the last decades, epidemiological data have demonstrated the high incidence of cardiovascular (CV) disease (CVD) in women. It seems that the current theory that women represent a low-risk population needs to be reconsidered. Women are more likely to be susceptible to unhealthy behaviors and...
The optimal dose of aspirin for secondary prevention in established atherosclerotic cardiovascular disease (ASCVD) has not been clearly determined (ESC guidelines recommend low dose aspirin, but ACC-AHA guidelines do not define a recommended dose) [98,99,100]. The ADAPTABLE (Comparative Effectiveness ...
We summarize the 2016 update of the 2004 Agency of Healthcare Research and Quality′s evidence review of omega-3 fatty acids and cardiovascular disease (CVD). The overall findings for the effects of marine oil supplements on intermediate CVD outcomes remain largely unchanged. There is high strengt...
In an impressive attempt to improve secondary prevention therapy delivery, the SECURE (Secondary Prevention of Cardiovascular Disease in the Elderly Trial) trial [81] randomised 2499 patients with MI ≤ 6 months to an open label polypill, comprising aspirin 100 mg, ramipril (2.5, 5 or 10 mg) ...
asymptomatic, no structural heart disease nor cardiac biomarkers of stretch injury (eg, patients with hypertension, atherosclerotic cardiovascular disease, diabetes, metabolic syndrome and obesity, exposure to cardiotoxic agents, genetic variant for cardiomyopathy, or positive family history of cardiomyopathy)...
In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD. It is estimated that about 330 million patients suffer from CVD in China. The number of patients suffering from stroke...
Joint Scrutiny Review Panel on health inequalities with a focus on cardiovascular disease - summary 来自 cfps.org.uk 喜欢 0 阅读量: 38 作者: DC Council 摘要: The Centre for Public Scrutiny (CfPS) set up the Health InequalitiesScrutiny Programme to promote the use of scrutiny as a tool to ...
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of ... Collaborators: Kloeck W, Adrie C, Alhelail M, Battu P, Behringer W, Berkow L, Bernstein RA, Bhayani SS, Bigham B, Boyd J, Brenner...